Altered lipid metabolism in vasopressin V1B receptor-deficient mice

European Journal of Pharmacology

Volumn 602, Issue 2-3, 2009, Pages 455-461

  Hiroyama, Masami ^a,b   Fujiwara, Yoko ^a   Nakamura, Kazuaki ^a   Aoyagi, Toshinori ^a,c   Mizutani, Reiko ^a   Sanbe, Atsushi ^a   Tasaki, Ryuji ^d   Tanoue, Akito ^a  

^a NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^b SCIVAX Corporation   (Japan)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^d Chemo Sero Therapeutic Research Institute   (Japan)

Author keywords

Lipid; Metabolism; Vasopressin

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; FATTY ACID; GLUCOSE; GLYCEROL; ISOPRENALINE; LEPTIN; LIPID; VASOPRESSIN V1B RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CHOLESTEROL SYNTHESIS; CONTROLLED STUDY; EPIDIDYMIS FAT; FATTY ACID OXIDATION; GENE EXPRESSION; IN VITRO STUDY; INSULIN SENSITIVITY; LIPID METABOLISM; LIPOGENESIS; LIPOLYSIS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TANDEM MASS SPECTROMETRY;

ACETATE-COA LIGASE; ADIPOCYTES, WHITE; ADIPOKINES; ANIMALS; BODY WEIGHT; CELL DIFFERENTIATION; CHOLESTEROL; EPIDIDYMIS; FATTY ACIDS, NONESTERIFIED; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLUCOSE; HYDROXYMETHYLGLUTARYL COA REDUCTASES; INSULIN; LIPID METABOLISM; LIPOGENESIS; LIPOLYSIS; LIVER; MALE; MICE; OXIDATION-REDUCTION; RECEPTORS, VASOPRESSIN; TRIGLYCERIDES;

EID: 58149239864     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2008.11.043     Document Type: Article

References (34)

1. Aoyagi T., Birumachi J., Hiroyama M., Fujiwara Y., Sanbe A., Yamauchi J., and Tanoue A. Alteration of glucose homeostasis in V1a vasopressin receptor-deficient mice. Endocrinology 148 (2007) 2075-2084
2. Assimacopoulos-Jeannet F., Brichard S., Rencurel F., Cusin I., and Jeanrenaud B. In vivo effects of hyperinsulinemia on lipogenic enzymes and glucose transporter expression in rat liver and adipose tissues. Metabolism 44 (1995) 228-233
3. Bai Y., Zhang S., Kim K.S., Lee J.K., and Kim K.H. Obese gene expression alters the ability of 30A5 preadipocytes to respond to lipogenic hormones. J. Biol. Chem. 271 (1996) 13939-13942
4. Birnbaumer M. Vasopressin receptors. Trends Endocrinol. Metab. 11 (2000) 406-410
5. Considine R.V., Sinha M.K., Heiman M.L., Kriauciunas A., Stephens T.W., Nyce M.R., Ohannesian J.P., Marco C.C., McKee L.J., Bauer T.L., and Caro J.F. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N. Engl. J. Med. 334 (1996) 292-295
6. Egashira N., Tanoue A., Higashihara F., Fuchigami H., Sano K., Mishima K., Fukue Y., Nagai H., Takano Y., Tsujimoto G., Stemmelin J., Griebel G., Iwasaki K., Ikeda T., Nishimura R., and Fujiwara M. Disruption of the prepulse inhibition of the startle reflex in vasopressin V1b receptor knockout mice: reversal by antipsychotic drugs. Neuropsychopharmacology 30 (2005) 1996-2005
7. Farooqi I.S., Matarese G., Lord G.M., Keogh J.M., Lawrence E., Agwu C., Sanna V., Jebb S.A., Perna F., Fontana S., Lechler R.I., DePaoli A.M., and O'Rahilly S. Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency. J. Clin. Invest. 110 (2002) 1093-1103
8. Fujiwara Y., Hiroyama M., Sanbe A., Aoyagi T., Birumachi J.I., Yamauchi J., Tsujimoto G., and Tanoue A. Insulin hypersensitivity in mice lacking the V1b vasopressin receptor. J. Physiol. 584 (2007) 235-244
9. Fujiwara Y., Hiroyama M., Sanbe A., Yamauchi J., Tsujimoto G., and Tanoue A. Mutual regulation of vasopressin- and oxytocin-induced glucagon secretion in V1b vasopressin receptor knockout mice. J. Endocrinol. 192 (2007) 361-369
10. 2+-linked hormones angiotensin II, norepinephrine, and vasopressin stimulate the phosphorylation of distinct substrates in intact hepatocytes. J. Biol. Chem. 257 (1982) 13135-13143
11. Gelling R.W., Du X.Q., Dichmann D.S., Romer J., Huang H., Cui L., Obici S., Tang B., Holst J.J., Fledelius C., Johansen P.B., Rossetti L., Jelicks L.A., Serup P., Nishimura E., and Charron M.J. Lower blood glucose, hyperglucagonemia, and pancreatic alpha cell hyperplasia in glucagon receptor knockout mice. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 1438-1443
12. Hems D.A. Short-term hormonal control of hepatic carbohydrate and lipid catabolism. FEBS Lett. 80 (1977) 237-245
13. Hiroyama M., Aoyagi T., Fujiwara Y., Birumachi J., Shigematsu Y., Kiwaki K., Tasaki R., Endo F., and Tanoue A. Hypermetabolism of fat in V1a vasopressin receptor knockout mice. Mol. Endocrinol. 21 (2007) 247-258
14. Hiroyama M., Aoyagi T., Fujiwara Y., Oshikawa S., Sanbe A., Endo F., and Tanoue A. Hyperammonaemia in V1a vasopressin receptor knockout mice caused by the promoted proteolysis and reduced intrahepatic blood volume. J. Physiol. 581 (2007) 1183-1192
15. Hotamisligil G.S., Arner P., Caro J.F., Atkinson R.L., and Spiegelman B.M. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J. Clin. Invest. 95 (1995) 2409-2415
16. Kadowaki T., and Yamauchi T. Adiponectin and adiponectin receptors. Endocr. Rev. 26 (2005) 439-451
17. Keppens S., and de Wulf H. The nature of the hepatic receptors involved in vasopressin-induced glycogenolysis. Biochim. Biophys. Acta 588 (1979) 63-69
18. Kersten S. Mechanisms of nutritional and hormonal regulation of lipogenesis. EMBO Rep. 2 (2001) 282-286
19. Kubota N., Terauchi Y., Yamauchi T., Kubota T., Moroi M., Matsui J., Eto K., Yamashita T., Kamon J., Satoh H., Yano W., Froguel P., Nagai R., Kimura S., Kadowaki T., and Noda T. Disruption of adiponectin causes insulin resistance and neointimal formation. J. Biol. Chem. 277 (2002) 25863-25866
20. Liu J.L., Coschigano K.T., Robertson K., Lipsett M., Guo Y., Kopchick J.J., Kumar U., and Liu Y.L. Disruption of growth hormone receptor gene causes diminished pancreatic islet size and increased insulin sensitivity in mice. Am. J. Physiol., Endocrinol. Metab. 287 (2004) E405-E413
21. Michell R.H., Kirk C.J., and Billah M.M. Hormonal stimulation of phosphatidylinositol breakdown with particular reference to the hepatic effects of vasopressin. Biochem. Soc. Trans. 7 (1979) 861-865
22. Moller N., Gjedsted J., Gormsen L., Fuglsang J., and Djurhuus C. Effects of growth hormone on lipid metabolism in humans. Growth Horm. IGF Res. 13 Suppl A (2003) S18-S21
23. Oshikawa S., Tanoue A., Koshimizu T.A., Kitagawa Y., and Tsujimoto G. Vasopressin stimulates insulin release from islet cells through V1b receptors: a combined pharmacological/knockout approach. Mol. Pharmacol. 65 (2004) 623-629
24. Richardson S.B., Laya T., and VanOoy M. Similarities between hamster pancreatic islet beta (HIT) cell vasopressin receptors and V1b receptors. J. Endocrinol. 147 (1995) 59-65
25. Rofe A.M., and Williamson D.H. Metabolic effects of vasopressin infusion in the starved rat. Reversal of ketonaemia. Biochem. J. 212 (1983) 231-239
26. Siegrist-Kaiser C.A., Pauli V., Juge-Aubry C.E., Boss O., Pernin A., Chin W.W., Cusin I., Rohner-Jeanrenaud F., Burger A.G., Zapf J., and Meier C.A. Direct effects of leptin on brown and white adipose tissue. J. Clin. Invest. 100 (1997) 2858-2864
27. Sorensen H., Winzell M.S., Brand C.L., Fosgerau K., Gelling R.W., Nishimura E., and Ahren B. Glucagon receptor knockout mice display increased insulin sensitivity and impaired beta-cell function. Diabetes 55 (2006) 3463-3469
28. Spruce B.A., McCulloch A.J., Burd J., Orskov H., Heaton A., Baylis P.H., and Alberti K.G. The effect of vasopressin infusion on glucose metabolism in man. Clin. Endocrinol. (Oxf) 22 (1985) 463-468
29. Steppan C.M., Bailey S.T., Bhat S., Brown E.J., Banerjee R.R., Wright C.M., Patel H.R., Ahima R.S., and Lazar M.A. The hormone resistin links obesity to diabetes. Nature 409 (2001) 307-312
30. Tanoue A., Ito S., Honda K., Oshikawa S., Kitagawa Y., Koshimizu T.A., Mori T., and Tsujimoto G. The vasopressin V1b receptor critically regulates hypothalamic-pituitary-adrenal axis activity under both stress and resting conditions. J. Clin. Invest. 113 (2004) 302-309
31. Tebar F., Soley M., and Ramirez I. The antilipolytic effects of insulin and epidermal growth factor in rat adipocytes are mediated by different mechanisms. Endocrinology 137 (1996) 4181-4188
32. Thibonnier M. Vasopressin and blood pressure. Kidney Inter., Suppl. 25 (1988) S52-56
33. Wang M.Y., Lee Y., and Unger R.H. Novel form of lipolysis induced by leptin. J. Biol. Chem. 274 (1999) 17541-17544
34. Yibchok-anun S., and Hsu W.H. Effects of arginine vasopressin and oxytocin on glucagon release from clonal alpha-cell line In-R1-G9: involvement of V1b receptors. Life Sci. 63 (1998) 1871-1878